Nichi-Iko Manufacturing Plant Raided Over Illegal Production – Report
Raid Follows Earlier Suspension Of Sales And Production
Japanese generics giant Nichi-Iko had a key manufacturing plant raided by Japanese authorities and regulator the PMDA, per media reports, following the recent suspension of production and sales at the site in the Toyama prefecture.
You may also be interested in...
Nichi-Iko Set To Delist In March As Tamura Steps Down As CEO
After nearly two difficult years for Nichi-Iko Pharmaceutical, the firm has announced at it will be acquired by a private equity fund and delisted from the Toyko Stock Exchange in 2023 and its CEO will step down from his post.
Earnings Recovery For Nichi-Iko Unlikely Before Full Resumption Of Toyama Shipments
Nichi-Iko still has a long road to recovery ahead as it attempts to get its Toyama plant back on its feet.
Nichi-Iko Pledges Return To Form After Turbulent Financial Year
Nichi-Iko experienced substantial losses over the financial year ended 31 March 2022, as one of many Japanese generics firms found to have been falling short on GMP since the beginning of 2021.